Lenar Aimee J.
President, US Pharma
Lenar Aimee J. has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Aug 20, 2026.
On the most recent filing, Lenar Aimee J. is listed as President, US Pharma at Bausch Health Companies Inc. Inside the rolling window, Lenar Aimee J. reported no open-market purchases and 1 open-market sale totaling $259K in BHC.
Companies traded
Other insiders at BHC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$259K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Lenar Aimee J. made?
Lenar Aimee J. has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does Lenar Aimee J. trade?
Lenar Aimee J. has filed SEC Form 4 disclosures for 1 company, including BHC.
When was Lenar Aimee J.'s most recent SEC Form 4 filing?
Lenar Aimee J.'s most recent SEC Form 4 filing on Tracefour is dated Aug 20, 2026.
What is Lenar Aimee J.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Lenar Aimee J. is listed as President, US Pharma.
What is Lenar Aimee J.'s total buy and sell value in the current window?
Inside the rolling retention window, Lenar Aimee J. bought $0 and sold $259K based on SEC Form 4 filings.
What was Lenar Aimee J.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 36,827 BHC shares on 2026-08-19, worth $259K, per SEC Form 4 filings.